The KPMG trademarks are the sole property of KPMG International Cooperative
QIAGEN is the leading global provider of Sample to Insight solutions to transform biological materials into valuable molecular insights. QIAGEN sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective molecular testing workflows. QIAGEN provides these workflows to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research).
The National Diabetes Services Scheme (NDSS) is an initiative of the Australian Government, administered by Diabetes Australia. The purpose of the NDSS is to support self-management for all Australians affected by any type of diabetes. This is achieved by providing timely and affordable access to subsidised diabetes products, trusted information, resources and support programs to help people understand and manage their diabetes. Registration is free and open to people with diabetes with a Medicare card.